Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunoglobulin lambda variable pseudogenes are DNA sequences that resemble the variable region genes of immunoglobulin lambda light chains but are non-functional due to sequence changes or defects that prevent them from being expressed as a functional protein[1][4]. These pseudogenes are part of the immunoglobulin lambda locus but do not contribute to antibody production and are not expressed by B lymphocytes. Their presence reflects the complex evolutionary history of the immunoglobulin gene loci, which have undergone duplication and mutation events, generating both functional and non-functional gene segments[1][4]. Such pseudogenes do not encode proteins, do not bind antigen, have no role in immune function, and have no current relevance as drug targets or disease markers[1][3][4].\n\nKey additional details:\n- The immunoglobulin lambda locus contains both functional and pseudogene segments; the latter are conventionally assigned Roman numerals or labeled in nomenclature tables as non-functional[1].\n- Common lambda variable pseudogenes do not produce immune receptor proteins and are not implicated in immune signaling, disease, or pharmacology[1][3][4].\n- The designation "ENSG00000231331" corresponds to an Ensembl gene entry for a pseudogene segment in this family, but such entries are often absent from functional gene/protein/drug/biomarker databases[3].\n\nIn summary, immunoglobulin lambda variable group pseudogenes are not therapeutic targets and are not relevant for biomarker or drug interaction analysis in clinical or therapeutic settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin lambda variable pseudogene.